UGT1A1 and Decreased total neutrophil count: The United States of America Food and Drug Administration recognises the importance of UGT1A1 pharmacogenetics in predicting toxicity to irinotecan and describes the association between reduced enzymatic activity of the UGT1A1*28 allele and neutropenia after drug administration in their summary of product characteristics.